Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)

the coVAPid study group

Producción científica: Artículo CientíficoComentario/Debate

1 Cita (Scopus)

Resumen

Following publication of the original article [1], the authors identified an error in the Abstract and Results section. The correct numbers and text are given hereafter. Abstract VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 group (adjusted HR 1.65 (95% CI 1.11–2.46), p = 0.013), but not in influenza (1.74 (0.99–3.06), p = 0.052), or no viral infection groups (1.13 (0.68–1.86), p = 0.63). Results Primary and secondary outcomes: VAP was associated with higher risk for 28-day mortality in in SARS-CoV-2 group, but not in the two other groups (Fig. 2A). All the changes that were requested are implemented in this correction and the original article [1] has been corrected.

Idioma originalInglés estadounidense
-284
PublicaciónCritical Care
Volumen25
N.º1
DOI
EstadoIndizado - dic. 2021

Nota bibliográfica

Publisher Copyright:
© The Author(s) 2021

Huella

Profundice en los temas de investigación de 'Correction to: Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort (Critical Care, (2021), 25, 1, (177), 10.1186/s13054-021-03588-4)'. En conjunto forman una huella única.

Citar esto